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Background. The objective of this study was to examine whether cytomegalovirus (CMV), herpes simplex virus
type-1 (HSV-1), and C-reactive protein (CRP) are associated with functional impairment in older Latinos.
Methods. A cross-sectional analysis of a cohort study was conducted with a community-dwelling elderly population.
The sample was a subset (N¼ 1559/1789) of participants in the Sacramento Area Latino Study on Aging (SALSA) ages
60–101 with available serum samples and functional impairment measures. Baseline serum samples were assayed
for levels of immunoglobulin G antibodies to CMV and HSV-1 and for levels of CRP. Several measures were used to
assess functional impairment, including activities of daily living (ADL), instrumental activities of daily living (IADL), and
walking pace.
Results. CMV and CRP showed statistically significant graded associations with ADL functional impairment, even
after controlling for age and gender. The relationship between CMV and ADL was slightly attenuated, and the confidence
interval contained the null value when adjusted for total number of health conditions, body mass index, and household
income. Only high levels of CRP were significantly related to ADL and IADL impairment even after adjusting for all other
covariates.
Conclusion. Inflammation is clearly linked to physical functioning among aging Latinos. This study also suggests
a role for CMV infection in relation to ADL impairment. Further research examining the influence of infection, immune
response, and inflammation on longitudinal trajectories of physical functioning is warranted.
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FUNCTIONAL impairment, a common occurrence inaging, is generally measured as any difficulty that
interferes with or limits functioning in one or more major
life activities, including basic and instrumental activities of
daily living (ADL, IADL) (1–3). Research suggests that
physiologic processes such as the production of pro-
inflammatory complexes may underlie functional impair-
ment. Several studies have described a relationship between
markers such as C-reactive protein (CRP), interleukin-6 (IL-
6), and tumor necrosis factor-a (TNF-a) and measures of
functional impairment, physical decline, and walking speed,
in older populations (4–7). Ferrucci and colleagues (8)
suggest that overproduction of cytokines and maintenance
of the inflammatory state over a long period may lead to
physical degeneration in elderly populations.
It has also been reported that persistent infections may act
as proinflammatory agents and are involved as stimuli that
underlie and sustain the process of chronic inflammation (9–
11). For example, one study has shown that asymptomatic
chronic cytomegalovirus (CMV) infection is linked to
greater frailty in older women and that the relationship is
enhanced by IL-6 (9). Chronic latent infections, such as
CMV and herpes simplex virus-1 (HSV-1), have the
potential to induce chronic inflammatory states because
they undergo periodic reactivation, thereby triggering sub-
sequent inflammatory responses (10,12). CMV and HSV-1
infections often pass undiagnosed because of their asymp-
tomatic properties, and remain persistent in the system for
life, with an increasing risk of reactivation during old age
and in response to stress (13–16). More recently, immuno-
logical studies have suggested that aging populations
infected with CMV experience large clonal expansion of
CD8þ effector T cells resulting in a reduction in the
‘‘immunological space’’ and a loss of response to foreign
antigens other than CMV (17). Persistent CMV has been
called one of the ‘‘driving forces’’ behind age-related altera-
tions among T cells in elderly persons (18–20). The immu-
nological effects of persistent CMV and other herpesviruses,
such as HSV, may influence chronic conditions associated
with aging. In addition to frailty, infection with CMV has
been linked to cardiovascular disease, cognitive outcomes,
and Alzheimer’s disease (11,21–23).
Both CMV and HSV-1 are common worldwide and are
found in .83% of individuals 60 years old and older in
the United States (24,25). Factors such as age, gender, race/
ethnicity, and education are associated with HSV-1 and
CMV seropositivity (24,25). Ethnic differences in infection
have been found among persons 60–69 years old, with 95%
of Mexican Americans having antibody to HSV-1 compared
to 83% in non-Latino white populations (24). Similar
prevalence estimates as well as race/ethnic disparities have
been reported for CMV in the United States (25). Among
individuals who are seropositive for HSV-1 or CMV, factors
that may lead to higher levels of antibodies and possibly
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clinical reaction include stress, organ transplant, and immu-
nosuppression (10,26–28). Collectively, these data suggest
important roles for persistent infection and resultant chronic
inflammation in the development of older age functional
impairment, especially among minority populations such as
Mexican Americans.
To date, CMV has been assessed in relation to a compos-
ite measure of frailty among a group of predominantly
white women (9). There are no data, to our knowledge, that
have assessed the influence of CMV on measures of ADL,
IADL, and walking pace. In this study, we assess whether
persistent antibodies to CMV and HSV-1 and CRP levels




The participants were enrolled in the Sacramento Area
Latino Study on Aging (SALSA) study, which is a large,
ongoing prospective cohort study of predominantly Mexi-
can Americans living in the community, who were 60–101
years old at baseline in 1998–1999. More detailed infor-
mation on sampling frame, recruitment procedures, and
interviews are published elsewhere (29). At the end of
baseline, 1789 people were enrolled in the study. The results
of blood tests for infection and inflammatory markers were
available for 1559 participants of which 1507 had measure-
ments of ADL impairment, 1261 had measurements of
IADL impairment, and 1444 had measurements of walking
pace. Therefore, our analyses used these subgroups with
available data regarding infection, inflammation, ADL,
IADL, and walking pace impairment.
Study Design
Baseline data collection began in 1998–1999. Each
participant answered questions regarding sociodemographic
factors, lifestyle factors, acculturation, and medical di-
agnoses. Blood was drawn for measurement and analyses of
antibodies, inflammatory markers, lipids, glucose, and
insulin on the same day as the interview. Additionally,
participants completed several physical performance tests.
Laboratory Analyses
Baseline frozen serum samples were analyzed for both
CMV and HSV-1 infections and CRP levels. A standard
commercial, highly sensitive, enzyme-linked immunosor-
bent assay (ELISA) kit was used for detecting type-specific
immunoglobulin G (IgG) antibody responses to CMV and
HSV-1 (Wampole Laboratories, Princeton, NJ). Antibody
levels were measured by optical density units. The sen-
sitivity and specificity of the assay for HSV-1 are reported to
be 97.1% and 96.8%, respectively; for CMV, the sensitivity
and specificity are reported to be 99% and 94%, respec-
tively. Serum samples were also used to analyze levels of
CRP by means of the CRP Ultra Wide Range Reagent
Kit latex-enhanced immunoassay (Equal Diagnostics,
Exton, PA).
Functional Measures
ADL and IADL impairment was measured based on self-
reported functional status (2,30). The ADL measurement
consisted of seven items, and was used to measure ability to
perform activities such as walking across a small room,
bathing, eating, and using the toilet (1). The IADL measure-
ment consisted of 15 items and was used to measure ability
to perform activities as described earlier (3). Both the ADL
and IADL measurements used a standard Likert-type scale
(30). Additionally, a self-reported measure of walking pace
was used in which participants reported their usual walking
pace outdoors, using a multiple-category scale consisting
of, ‘‘Never walks outdoors,’’ ‘‘Unable to walk,’’ ‘‘Easy,
casual,’’ ‘‘Normal, average,’’ ‘‘Brisk pace,’’ or ‘‘Very brisk/
striding’’ (31).
Covariates
Age and gender of each participant were recorded.
Birthplace was measured by asking participants for their
country of birth. Self-reported gross household income was
measured based on last month’s income, and educational
attainment by asking the total number of school years
completed. A modified Charlson comorbidity index was
created to control for the effect of chronic health conditions
on functional impairment. Points were assigned for having
myocardial infarction, congestive heart failure, stroke,
dementia, liver disease, diabetes, renal disease, any malig-
nancy, and leukemia or lymphoma and then summed to
generate a comorbidity score for each participant. The
following conditions were not included in the modified
index due to lack of data: peripheral vascular disease, cere-
brovascular disease, chronic pulmonary disease, connective
tissue disease, ulcer disease, hemiplegia, diabetes with end
organ damage, and acquired immunodeficiency syndrome
(AIDS). In addition, it was not possible to differentiate
severity of liver disease and renal disease or differentiate
between leukemia and malignant lymphomas. Body mass
index (BMI) at baseline was calculated using measured
height and weight. Smoking status was measured in pack-
years.
Statistical Analyses
Statistical analyses were performed using SAS (version
9.1; SAS Institute, Cary, NC). Baseline demographic
analysis was carried out using t tests for difference in
means and chi-squared tests for differences in proportions or
for trends among demographic groupings. All significance
tests were two-tailed, and p values , .05 were considered
statistically significant.
Each of the 7 ADL and 15 IADL outcome measures were
transformed from the Likert-type scale into a binary vari-
able. A response of ‘‘no difficulty’’ in completing an activity
was defined as having no difficulty and assigned a score of
0. Responses of ‘‘some difficulty,’’ ‘‘a lot of difficulty,’’ or
‘‘only with help from a person or equipment’’ were defined
as having difficulty and assigned a score of 1. A summary
score was created as a continuous variable for ADL and
IADL (range 0–7 and 0–15, respectively) and then trans-
formed into a binary variable. The final binary ADL variable
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was dichotomized as: (1) difficulty in one or more activities
or (2) no difficulty in activities. The final binary IADL
variable was dichotomized as: (1) difficulty in three or more
activities, or (2) difficulty in two or fewer activities. This
method of dichotomizing ADL and IADL has been used
elsewhere (32). CMV and HSV-1 antibody titer and CRP
level were assessed as continuous variables and in tertiles to
generate odds ratios. Because continuous CRP levels were
not normally distributed, values were transformed using
natural logarithm. Lastly, outdoor walking pace was trans-
formed into a binary variable in which a response of ‘‘Easy,
casual’’ or ‘‘Unable to walk’’ was defined as having a
walking pace below average and a response of ‘‘Normal,
average,’’ ‘‘Brisk pace,’’ or ‘‘Very brisk/striding’’ was
defined as having a walking pace at or above average.
Participants who responded, ‘‘Never walks outdoors’’ were
omitted (N ¼ 51).
Binary logistic regression was conducted to assess the
relationship between each predictor variable (CMV, HSV-1,
and CRP) and each outcome of interest (ADL, IADL, and
walking pace). First, unadjusted associations between
each exposure and outcome were assessed using odds ratios
and 95% confidence intervals (CI). Variables that were sig-
nificantly associated with both the main predictors and
outcomes of interest in bivariate analyses and were not
hypothesized to be mediators were included as potential
confounders in the models. Factors such as age, gender,
socioeconomic status, chronic health conditions, BMI,
birthplace, and smoking status were examined because
they have been shown to be potential confounders of
either the exposures or functional impairment outcomes
(4,6,8,9,25,32,33).
RESULTS
Comparisons of demographic and clinical characteristics
by ADL, IADL, and walking pace impairment are shown in
Table 1. Twelve percent of participants reported having
difficulty completing one or more ADL, and for IADL,
42% reported having difficulty completing three or more
activities. Increased age, female gender, lower monthly
income, and lower educational attainment were significantly
associated with having difficulty in ADL and IADL.
Twenty-seven percent of participants reported below aver-
age walking pace. Increased age, female gender, birthplace,
lower monthly income, and lower educational attainment
were significantly associated with below average walking
pace.
Clinical characteristics such as BMI, smoking status, and
total chronic health conditions (modified Charlson comor-
bidity index) were also assessed in relation to ADL and
IADL difficulties (see Table 1). There was no significant
difference in BMI by ADL difficulties. In contrast, the mean
BMI among participants with IADL difficulties was signifi-
cantly higher than that among participants without difficul-
ties. Participants with difficulties in ADL and IADL and
below average walking pace had significantly more chronic
health conditions.
Of the 1559 participants, approximately 96% were
considered CMV seropositive (i.e., having signs of prior
exposure) by the ELISA testing cut points, and 98% were
found seropositive for HSV-1. There were only small
differences in seropositivity by ADL and IADL impairment.
CMV and HSV-1 antibody titers were significantly higher
among those with ADL difficulties (p ¼ .0003) and (p ¼
.0078), respectively (see Figure 1). CMV was significantly
higher among those with IADL difficulties (p¼ .0083) and
those with below average walking pace (p ¼ .0067) (see
Figure 1). Mean CRP levels were significantly higher
among those with ADL and IADL difficulty (p¼ .0042 and
p , .0001, respectively) (see Figure 1). Mean CRP levels
were also significantly higher among those with below
average walking pace versus above average walking pace
(p , .0001). CMV was significantly correlated with CRP
(r ¼ 0.1156, p , .0001), but there was no significant cor-
relation between HSV and CRP or between HSV and CMV.
Association Between Infection, Inflammation, and
ADL Difficulty
Table 2 shows the associations between CMV and HSV-1
infection and CRP in relation to ADL impairment in
unadjusted and adjusted models. Figure 2 shows that, after
adjustment for age and gender, a statistically significant
association was observed between ADL difficulty and the
highest tertile of CMV antibody titer. For CMV, statistical
significance was lost in the fully adjusted model, and the
odds ratio was reduced by 27% compared to the unadjusted
model, but the graded relationship between increasing CMV
levels and difficulty was still evident. A statistically signifi-
cant relationship between the middle and highest level of
CRP and ADL difficulty was evident before and after
control for age and gender (Table 2), but the relationship
was no longer significant after controlling for age, gender,
education, income, and total number of chronic health con-
ditions (Figure 3). Increasing HSV-1 levels were not asso-
ciated with ADL impairment.
Association Between Infection, Inflammation, and
IADL Difficulty
In the unadjusted analysis, there was a significant
association between being in the highest tertile of CMV
antibody titer and IADL difficulty (see Table 3). After full
adjustment, there was no association between being in the
highest tertile of CMV and IADL difficulty. HSV-1 levels
were not associated with IADL difficulty. There were sig-
nificantly higher odds of IADL difficulty among participants
in the middle and high CRP tertiles (see Table 3). After full
adjustment, only high levels of CRP remained significantly
associated with difficulty completing IADL.
Association Between Infection, Inflammation, and
Walking Pace
In the unadjusted analysis, higher CMV antibody levels
and higher CRP levels were significantly associated with
a below average outdoor walking pace (see Table 4). After
adjusting for covariates, the only significant relationship that
remained was between high CRP level and below average
walking pace.
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DISCUSSION
This study of older Latinos suggests a consistent cross-
sectional association between high CRP levels and three
self-reported measures of functional impairment. There was
also a significant graded association with CMV and ADL
difficulties, but after adjustment for comorbidities the odds
ratio was reduced and no longer significant. HSV-1, in
contrast, showed no evidence of a relationship with ADL,
IADL, or walking pace.
Only one other study at this time, by Schmaltz and
colleagues (9), has looked at the association of persistent
infection and a functional measure in older populations.
They used a dichotomous measure of CMV infection status
(positive or negative) and a composite measure of frailty as
an outcome (9). In our study, however, continuous measures
of both CMV and HSV-1 infection (antibody responses)
were used because these infections were found to be highly
prevalent in the study population, and it is likely that an
increased antibody level may be a better reflection of the
intensity of exposure and immune response to these
infections over the life course (11,19). Moreover, the study
by Schmaltz and colleagues focused solely on white elderly
women, whereas this study analyzed data from a large
population of men and women, primarily of Mexican
American or Mexican descent. Given the differences in
demographic and infection measures between these two
studies, we cannot directly compare our results to those of
Schmaltz and colleagues (9). However, our results regarding
Table 1. Demographic and Clinical Characteristics by ADL, IADL, and Walking Pace in the SALSA Study





















Mean 6 SD 69.79 6 6.36 73.88 6 8.57 ,.0001* 68.75 6 5.74 71.30 6 7.19 ,.0001* 69.38 6 5.99 71.69 6 7.41 ,.0001*
Category, n (%)
60–69 693 (91.55) 64 (8.45) ,.0001* 426 (64.55) 234 (35.45) ,.0001* 561 (76.02) 177 (23.98) ,.0001*
70–79 536 (88.89) 67 (11.11) 281 (56.09) 220 (43.91) 426 (73.32) 155 (26.68)
80 103 (70.07) 44 (29.93) 29 (29.00) 71 (71.00) 60 (48.00) 65 (52.00)
Gender
Male 564 (90.53) 59 (9.47) .0293* 364 (69.33) 161 (30.67) ,.0001* 456 (75.62) 147 (24.38) .0248*
Female 768 (86.88) 116 (13.12) 372 (50.54) 364 (49.46) 591 (70.27) 250 (29.73)
Country of Birth
United States 688 (89.12) 84 (10.88) .3636 388 (58.17) 279 (41.83) .8814 516 (69.73) 224 (30.27) .0154*
Mexico/Other
Latin country
644 (87.62) 91 (12.38) 348 (58.59) 246 (41.41) 531 (75.43) 173 (24.57)
Monthly income
,1,000 535 (83.99) 102 (16.01) ,.0001* 239 (47.14) 268 (52.86) ,.0001* 417 (68.81) 189 (31.19) .0006*
1,000–1,999 417 (89.68) 48 (10.32) 232 (60.26) 153 (39.74) 322 (72.36) 123 (27.64)
2,000 361 (94.75) 20 (5.25) 254 (72.78) 95 (27.22) 292 (79.13) 77 (20.87)
Education (y), n (%):
0–3 385 (83.70) 75 (16.30) ,.0001* 176 (50.29) 174 (49.71) ,.0001* 304 (70.37) 128 (29.63) .0143*
4–11 513 (88.30) 68 (11.70) 275 (56.58) 211 (43.42) 392 (70.00) 168 (30.00)
12 434 (93.13) 32 (6.87) 285 (67.06) 140 (32.94) 351 (77.65) 101 (22.35)
Charlson comorbidity index score category, n (%)
0–3 1285 (89.11) 157 (10.89) ,.0001* 714 (59.06) 495 (40.94) .0126* 1018 (73.55) 366 (26.45) ,.0001*
4–6 46 (71.88) 18 (28.13) 22 (43.14) 29 (56.68) 29 (49.15) 30 (50.85)
7–9 1 (100.0) 0 (0.00) 0 (0.00) 1 (100.00) 0 (0.00) 1 (100.00)
BMI
Mean 6 SD 29.61 6 5.60 29.98 6 7.86 .5537 28.98 6 5.29 30.47 6 6.25 ,.0001* 29.38 6 5.52 30.48 6 6.35 .0028*
Smoking (pack-years)
Mean 6 SD 10.30 6 20.91 10.10 6 22.49 .8824 10.79 6 22.63 9.45 6 17.90 .2607 10.03 6 21.96 11.42 6 19.53 .2439
Category, n (%)
Never smoker 637 (88.84) 80 (11.16) .5995 334 (56.13) 261 (43.87) .1286 508 (74.82) 171 (25.18) .0641
Ever smoker 695 (87.97) 95 (12.03) 402 (60.36) 264 (39.64) 539 (70.46) 226 (29.54)
Notes: Difficulty in activities of daily living (ADL) defined as difficulty in 1 activities. Difficulty in instrumental activities of daily living (IADL) defined as
difficulty in 3 activities. Difficulty in walking pace defined as below average walking pace versus at or above average walking pace. For ADL, 24 participants were
missing values on income and 12 participants were missing values on body mass index (BMI). For IADL, 20 participants were missing values on income and 7
participants were missing values on BMI. For walking pace, 24 participants were missing values on income and 11 participants were missing values on BMI.
*p value based on an independent samples t test or chi-square tests for trend or differences in proportions.
SALSA ¼ Sacramento Area Latino Study on Aging; SD ¼ standard deviation.
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the relationship between CMV specifically and ADL
impairment are further evidence supporting a potential
relationship between this persistent infection and measures
of physical functioning.
A major strength of this study is that, to our knowledge,
this is the first study to examine collectively the relation-
ships among multiple markers of persistent infection, an
infection-related inflammatory marker, and three validated
Figure 1. Mean cytomegalovirus (CMV) and herpes simplex virus type-1 (HSV-1) antibody levels and log C-reactive protein (CRP) by levels of difficulty in
activities of daily living (ADL), instrumental activities of daily living (IADL) and walking pace. Plots show the mean and standard error bars for CMV and HSV-1
immunoglobulin (IgG) antibody optical density units (OD) and (ln) natural log CRP levels by ADL and IADL difficulty status, and walking pace. For ADL: ND, no
difficulty; D, difficulty in 1 activities. For IADL: ND, no difficulty in 2 activities; D, difficulty in 3 activities. For walking pace: A, at or above average walking
pace; B, below average walking pace. *Significant at p , .05.
Table 2. Associations Between CMV Infection, HSV-1 Infection, CRP, and ADL in the SALSA Study
Model 1 Model 2 Model 3
Exposure in Tertiles OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
CMV (N ¼ 1507):
Low 1.000 1.000 1.000
Middle 1.365 (0.895–2.083) .1482 1.244 (0.808–1.914) .3220 1.215 (0.773–1.910) .3995
High 2.037 (1.369–3.032)* .0005 1.551 (1.021–2.358)* .0399 1.411 (0.911–2.185) .1232
HSV-1 (N ¼ 1507):
Low 1.000 1.000 1.000
Middle 1.255 (0.840–1.876) .2667 1.266 (0.839–1.909) .2606 1.257 (0.826–1.913) .2859
High 1.437 (0.970–2.130) .0706 1.453 (0.971–2.175) .0691 1.352 (0.895–2.042) .1525
CRP (N ¼ 1506):
Low 1.000 1.000 1.000
Middle 1.532 (1.014–2.314)* .0430 1.564 (1.024–2.388)* .0384 1.443 (0.931–2.236) .1006
High 1.842 (1.235–2.748)* .0027 1.925 (1.271–2.915)* .0020 1.528 (0.990–2.358) .0556
Notes: Activities of daily living (ADL) outcome defined as difficulty in 1 activities versus no difficulty. Model 1: Unadjusted. Model 2: Adjusted for age and
gender. Model 3: Model with cytomegalovirus (CMV) adjusted for age, gender, education, modified Charlson comorbidity index and income; model with herpes
simplex virus type-1 (HSV-1) adjusted for age, gender, income, and education; and model with C-reactive protein (CRP) adjusted for age, gender, income, and
modified Charlson comorbidity index. The total N was reduced by 24 participants for exposure to CMV, HSV-1, and CRP in Model 3 due to missing data on income
and body mass index.
*Significant at p , .05.
SALSA ¼ Sacramento Area Latino Study on Aging; OR ¼ odds ratio; CI ¼ confidence interval.
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measures of physical functioning. In addition, our statistical
models controlled for many known risk factors for func-
tional impairment, such as age, comorbid health conditions,
and BMI (33,34). In addition, all of the laboratory testing
of the biological markers was conducted using validated
test kits with high sensitivity and specificity and the use of
positive and negative controls.
Although a graded association between CMV and ADL
impairment was observed after full adjustment for covariates
such as health conditions, income, and BMI, the effect
Figure 2. The association between cytomegalovirus (CMV), herpes simplex virus type-1 (HSV-1), antibody levels, and activities of daily living (ADL) in the
Sacramento Area Latino Study on Aging (SALSA) study. Odds ratios (OR) and 95% confidence intervals for ADL difficulty according to low (L), middle (M), and
high (H) tertiles of CMV and HSV-1 immunoglobulin G antibody optical density units. OR values compare the middle and high antibody tertiles to the lowest tertile as
the referent category. *Significant at p , .05.
Figure 3. Association between C-reactive protein (CRP) level and activities of daily living (ADL) in the Sacramento Area Latino Study on Aging (SALSA) study.
Odds ratios (OR) and 95% confidence intervals for ADL difficulty according to low, middle, and high tertiles of (ln) natural log CRP levels. The OR values compare
the middle and high antibody tertiles to the lowest tertile as the referent category. *Significant at p , .05.
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estimates were no longer statistically significant. Given that
control for factors such as chronic health conditions reduces
the relationship between CMV and ADL impairment, it is
possible that chronic health conditions associated with aging
may concurrently lead to higher levels of CMV antibodies and
functional impairments in aging populations. Both CMV and
HSV-1 have been implicated as initiators of chronic in-
flammation–related conditions including cardiovascular dis-
ease and Alzheimer’s disease (22,23). A longitudinal study is
needed to more clearly explicate the temporal relationships
among CMV antibody levels and physical decline. The
reactivation of persistent CMV infection has been associated
with activation of inflammatory molecules, such as increased
levels of CRP and IL-6 (10). However, in this cross-sectional
analysis, CRP levels were weakly correlated with CMV. It
may be worthwhile, however, to further explore the relation-
ship between CMV infection and cytokines such as IL-6, in
relation to ADL and IADL impairment.
Our earlier research in the SALSA population showed
a significant relationship between CMV antibody levels and
cognitive decline over a 5-year period, but no relationship
with HSV-1 (11). Similarly, there were no associations
Table 3. Associations Between CMV Infection, HSV-1 Infection, CRP Level, and IADL in the SALSA Study
Model 1 Model 2 Model 3
Exposure in Tertiles OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
CMV (N ¼ 1261):
Low 1.000 1.000 1.000
Middle 0.953 (0.722–1.257) .7306 0.809 (0.606–1.079) .1490 0.757 (0.560–1.024) .0712
High 1.405 (1.070–1.845)* .0144 1.037 (0.776–1.385) .8071 0.962 (0.711–1.300) .8000
HSV-1 (N ¼ 1261):
Low 1.000 1.000 1.000
Middle 1.021 (0.778–1.340) .8807 1.060 (0.799–1.406) .6882 1.036 (0.775–1.384) .8108
High 0.890 (0.675–1.173) .4087 0.926 (0.695–1.234) .5985 0.860 (0.641–1.156) .3177
CRP (N ¼ 1260):
Low 1.000 1.000 1.000
Middle 1.328 (1.005–1.755)* .0464 1.296 (0.969–1.734) .0802 1.089 (0.802–1.478) .5863
High 2.121 (1.606–2.800)* ,.0001 1.981 (1.478–2.655)* ,.0001 1.494 (1.090–2.048)* .0127
Notes: Instrumental activities of daily living (IADL) outcome defined as difficulty in 3 activities versus ,3 activities. Model 1: Unadjusted. Model 2: Adjusted
for age and gender. Model 3: Models with cytomegalovirus (CMV) adjusted for age, gender, income, education, and modified Charlson index; models with herpes
simplex virus type-1 (HSV-1) adjusted for age, gender, income, and education; and model with C-reactive protein (CRP) adjusted for age, gender, income, modified
Charlson comorbidity index and body mass index (BMI). The total N was reduced by 20 participants for exposure to CMV and HSV-1 and by 27 participants for
exposure to CRP in Model 3 due to missing data on income and BMI.
*Significant at p , .05.
SALSA ¼ Sacramento Area Latino Study on Aging; OR ¼ odds ratio; CI ¼ confidence interval.
Table 4. Associations Between CMV Infection, HSV-1 Infection, CRP Level, and Walking Pace in the SALSA Study
Model 1 Model 2 Model 3
Exposure in Tertiles OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
CMV (N ¼ 1444):
Low 1.000 1.000 1.000
Middle 0.952 (0.712–1.273) .7389 0.880 (0.654–1.184) .3985 0.866 (0.637–1.178) .3588
High 1.418 (1.072–1.876)* .0144 1.190 (0.888–1.595) .2444 1.140 (0.842–1.542) .3966
HSV-1 (N ¼ 1444):
Low 1.000 1.000 1.000
Middle 1.104 (0.834–1.461) .4897 1.102 (0.829–1.467) .5031 1.098 (0.821–1.469) .5277
High 0.999 (0.750–1.332) .9971 1.015 (0.758–1.358) .9212 0.964 (0.715–1.300) .8093
CRP (N ¼ 1443):
Low 1.000 1.000 1.000
Middle 1.348 (1.000–1.815)* .0496 1.324 (0.978–1.793) .0691 1.222 (0.895–1.667) .2073
High 2.009 (1.508–2.675)* ,.0001 2.021 (1.504–2.717)* ,.0001 1.710 (1.258–2.324)* .0006
Notes: Walking pace outcome was defined as below average walking pace versus at or above average walking pace. Model 1: Unadjusted. Model 2: Adjusted for age
and gender. Model 3: Models with cytomegalovirus (CMV) adjusted for age, gender, income, Charlson comorbidity index, and education; models with herpes simplex
virus type-1 (HSV-1) adjusted for age, gender, income, and country of birth; models with C-reactive protein (CRP) adjusted for age, gender, income, nativity, and
modified Charlson comorbidity index. The total N was reduced by 24 participants for exposure to CMV, HSV-1, and CRP in Model 3 due to missing data on income.
*Significant at p , .05.
SALSA ¼ Sacramento Area Latino Study on Aging; OR ¼ odds ratio; CI ¼ confidence interval.
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between HSV-1 IgG antibody levels and measures of
functional impairment. It is possible that HSV-1 infection
may still be related to decline in functioning over time.
However, the specificity of the association with CMV in our
study and the consistency with other researcher’s findings
(9) suggests that CMV, in particular, may be an important
indicator of physical functioning.
Several studies have observed a heightened IgG antibody
response to CMV as well as other herpesviruses in older
compared to younger persons (13–15). For example, a recent
study by Stowe and colleagues (35) reported a 4 unit higher
average serum CMV IgG antibody level among persons 66
years old or older compared to persons 25–55 years old (p ,
.0001) (35). Stowe and colleagues also identified detectable
CMV DNA in the urine of the old individuals but did not
identify CMV DNA in the blood (35). They suggest that the
presence of heightened serum CMV antibody levels in com-
bination with CMV DNA in urine only is a sign of frequent
CMV reactivation that occurs at subclinical levels in old
persons (35). Cell-mediated control is important for keeping
persistent viral infections such as HSV-1 and CMV from
reactivating (16,36,37). Changes in cell-mediated immune
parameters often occurs with aging (19,38). For these
reasons, it is likely that higher IgG antibody titers to CMV
among infected aging populations is correlated with sub-
clinical reactivation.
It is unclear how CMV might directly influence physical
functioning, but indirect pathways may include changes in
cellular components of immune function. Recently, several
researchers have identified CMV as an important component
of an immune risk phenotype that is associated with immu-
nosenescence, inflammation, and several chronic health
conditions observed with aging (19). CMV infection occurs
early in life, and CD8þCD28 cells are generated to
maintain control over persistent CMV infection over the life
course (39). Wikby and colleagues (39) recently demon-
strated that CMV induces changes in the CD4 T-cell com-
partment that are different than what usually occurs during
aging and emphasized the importance of considering CMV
status when examining immunosenescent changes in the
elderly population. Longitudinal data assessing the inter-
action between CMV, specific cellular markers, and inflam-
mation in relation to physical decline is necessary.
ADL, IADL, and walking pace impairment were found to
be significantly associated with increasing levels of CRP.
These results are consistent with those from previous studies
that have examined various markers of inflammation and
measures of physical functioning in elderly populations
(4,8,40). High CRP levels have been associated with loss of
muscle strength and mass in older men and women and have
been found to be an important factor in cardiovascular
conditions, type 2 diabetes, and metabolic syndrome
(41,42). Inflammation and health conditions, in turn, impact
physical function and functional impairment. Nonetheless,
the relationship between CRP and physical functioning in
our study was independent of comorbid conditions, such as
diabetes and cardiovascular conditions, and BMI, suggest-
ing that CRP influences physical functioning via other
pathophysiological processes.
A few limitations must be considered. First, this is
a cross-sectional study; therefore, caution should be taken in
making temporal inferences. However, CMV infection often
occurs in childhood, antibody levels to persistent herpesvi-
rus infections are generally stable over time, and CRP is
known to increase in response to infection, suggesting that
CMV antibody response would biologically precede CRP
increases (25,43).
Second, we used a modified version of the Charlson
comorbidity index because some of the conditions that are
generally applied to this index were not available for our
study population. However, the variables that we did
include in the modified index are known to be important
factors associated with increases in CRP and possibly CMV,
such as myocardial infarction and liver disease. In addition,
the application of the Charlson comorbidity index in this
population may be overly stringent because our population
is a community-dwelling sample and the index is generally
applied to patients who are already ill in the clinical setting.
It is also possible that Mexican Americans possess unique
characteristics that impact their exposure and response to
CMV infection (25) as well as functional decline. For
example, factors such as country of birth, age at migration,
and duration since migration to the United States might
influence both exposure to CMV infection and physical
activities. CMV was highly prevalent among our study
sample, and birthplace was associated with walking pace,
suggesting potential cultural differences in general walking
speed by place of birth. Therefore, the results of this study
may be specific to individuals with characteristics similar to
the SALSA study population.
Conclusion
This study provides further evidence that CRP and
possibly infection with CMV may have important roles in
the aging process, and more specifically, functional impair-
ment. Further longitudinal studies examining the influence
of CRP and persistent infections are needed to more fully
elucidate the biological roles and underlying mechanisms
associated with physical decline and the aging process. The
clinical implications of this study indicate that preventive
efforts targeting inflammation and possibly persistent infec-
tion may help enhance physical functioning among aging
Latinos.
ACKNOWLEDGMENTS
Funding for the SALSA study was aided by a grant from the National
Institute on Aging, National Institutes of Health (AG12975). This work
used the Chemistry Core of the Michigan Diabetes Research and Training
Center funded by NIH5P60 DK20572 and DK60753 from the National
Institute of Diabetes and Digestive and Kidney Diseases. We also
acknowledge (1) the Robert Wood Johnson Health & Society Scholar
grant at the University of Michigan (045823) for funding the viral testing
and (2) the University of Michigan Medical School, Institute of
Gerontology for fellowship support of A.E. Aiello. The only role that the
sponsors had was financial support.
A. E. Aiello conceived the aims of the study, assisted in the statistical
analyses, and led the writing of the manuscript. M. N. Haan is the Principal
Investigator for the SALSA study and contributed to the design, concepts,
and writing of the manuscript. J. Liang contributed to the concepts and
design of the study. A. M. Simanek and C.M. Pierce assisted with model
building and statistical analyses of the data as well as aided in writing drafts
of the manuscript.
617PERSISTENT INFECTION AND PHYSICAL FUNCTION
CORRESPONDENCE
Address correspondence to Allison E. Aiello, PhD, Assistant Professor of
Epidemiology, Department of Epidemiology, Center for Social Epidemi-
ology & Population Health, 1214 S. University, 2nd Floor, Ann Arbor, MI
48104-2548. E-mail: aielloa@umich.edu
REFERENCES
1. Katz S, Downs TD, Cash HR, et al. Progress in development of the
index of ADL. Gerontologist. 1970;10:20–30.
2. Spector WD, Katz S, Murphy JB, et al. The hierarchical relationship
between activities of daily living and instrumental activities of daily
living. J Chronic Dis. 1987;40:481–489.
3. Lawton MP, Brody EM. Assessment of older people: self-maintaining
and instrumental activities of daily living. Gerontologist. 1969;9:179–
186.
4. Ravaglia G, Forti P, Maioli F, et al. Peripheral blood markers of in-
flammation and functional impairment in elderly community-dwellers.
Exp Gerontol. 2004;39:1415–1422.
5. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of
inflammatory pathways in the development of functional decline and
mortality in the elderly. Am J Med. 2003;114:180–187.
6. Taaffe DR, Harris TB, Ferrucci L, et al. Cross-sectional and prospective
relationships of interleukin-6 and C-reactive protein with physical
performance in elderly persons: MacArthur studies of successful aging.
J Gerontol Med Sci. 2000;55A:M709–M715.
7. Enright PL, McBurnie MA, Bittner V, et al. The 6-min walk test: a
quick measure of functional status in elderly adults. Chest. 2003;123:
387–398.
8. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the
development of disability in older persons. J Am Geriatr Soc. 1999;
47:639–646.
9. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus
infection and inflammation are associated with prevalent frailty in
community-dwelling older women. J Am Geriatr Soc. 2005;53:747–
754.
10. Soderberg-Naucler C. Does cytomegalovirus play a causative role in
the development of various inflammatory diseases and cancer? J Intern
Med. 2006;259:219–246.
11. Aiello A, Haan M, Blythe L, et al. The influence of latent viral infection
on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:
1046–1054.
12. Padgett DA, Sheridan JF, Dorne J, et al. Social stress and the
reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci
U S A. 1998;95:7231–7235.
13. Musiani M, Zerbini M, Zauli D, et al. Impairment of cytomegalovirus
and host balance in elderly subjects. J Clin Pathol. 1988;41:722–725.
14. Musiani M, Zerbini ML, Muscari A, et al. Antibody patterns against
cytomegalovirus and Epstein-Barr virus in human atherosclerosis.
Microbiologica. 1990;13:35–41.
15. Weymouth LA, Gomolin IH, Brennan T, et al. Cytomegalovirus
antibody in the elderly. Intervirology. 1990;31:223–229.
16. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction:
implications for health. Nat Rev Immunol. 2005;5:243–251.
17. Almanzar G, Schwaiger S, Jenewein B, et al. Long-term cytomegalo-
virus infection leads to significant changes in the composition of the
CD8þ T-cell repertoire, which may be the basis for an imbalance in
the cytokine production profile in elderly persons. J Virol. 2005;79:
3675–3683.
18. Koch S, Solana R, Dela Rosa O, et al. Human cytomegalovirus
infection and T cell immunosenescence: a mini review. Mech Ageing
Dev. 2006;127:538–543.
19. Pawelec G, Koch S, Franceschi C, et al. Human immunosenescence:
does it have an infectious component? Ann N Y Acad Sci. 2006;1067:
56–65.
20. Mattay VS, Fera F, Tessitore A, et al. Neurophysiological correlates of
age-related changes in working memory capacity. Neurosci Lett.
2006;392:32–37.
21. Liu R, Moroi M, Yamamoto M, et al. Presence and severity of
Chlamydia pneumoniae and cytomegalovirus infection in coronary
plaques are associated with acute coronary syndromes. Int Heart J.
2006;47:511–519.
22. Sorlie PD, Nieto FJ, Adam E, et al. A prospective study of
cytomegalovirus, herpes simplex virus 1, and coronary heart disease:
the atherosclerosis risk in communities (ARIC) study. Arch Intern Med.
2000;160:2027–2032.
23. Itzhaki RF, Dobson CB, Shipley SJ, et al. The role of viruses and of
APOE in dementia. Ann N Y Acad Sci. 2004;1019:15–18.
24. Schillinger JA, Xu F, Sternberg MR, et al. National seroprevalence and
trends in herpes simplex virus type 1 in the United States, 1976–1994.
Sex Transm Dis. 2004;31:753–760.
25. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cyto-
megalovirus infection in the United States, 1988–1994. Clin Infect Dis.
2006;43:1143–1151.
26. Glaser R, Gotlieb-Stematsky T. Human Herpes Virus Infections:
Clinical Aspects. New York: Marcel Dekker; 1982.
27. Hirata M, Terasaki PI, Cho YW. Cytomegalovirus antibody status and
renal transplantation: 1987–1994. Transplantation. 1996;62:34–37.
28. Sarid O, Anson O, Yaari A, et al. Human cytomegalovirus salivary
antibodies as related to stress. Clin Lab. 2002;48:297–305.
29. Haan MN, Mungas DM, Gonzalez HM, et al. Prevalence of dementia in
older Latinos: the influence of type 2 diabetes mellitus, stroke and
genetic factors. J Am Geriatr Soc. 2003;51:169–177.
30. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged.
the index of ADL: a standardized measure of biological and psy-
chosocial function. JAMA. 1963;185:914–919.
31. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of
a self-administered physical activity questionnaire. Int J Epidemiol.
1994;23:991–999.
32. Wu JH, Haan MN, Liang J, et al. Diabetes as a predictor of change in
functional status among older Mexican Americans: a population-based
cohort study. Diabetes Care. 2003;26:314–319.
33. Jung SH, Ostbye T, Park KO. A longitudinal study of the relationship
between health behavior risk factors and dependence in activities of
daily living. J Prev Med Pub Health. 2006;39:221–228.
34. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of
the inflammation and coagulation systems with and without clinical
comorbidities: results from the Cardiovascular Health Study. Arch
Intern Med. 2002;162:2333–2341.
35. Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus
reactivation occurs in aging. Exp Gerontol. 2007;42:563–570.
36. Cytomegaloviruses: Molecular Biology and Immunology. Norfolk,
U.K.: Caister Academic Press; 2006.
37. Rawls W. Herpes simplex virus. In: Virology. New York: Raven Press;
1985.
38. De Martinis M, Franceschi C, Monti D, et al. Inflamm-ageing and
lifelong antigenic load as major determinants of ageing rate and
longevity. FEBS Lett. 2005;579:2035–2039.
39. Wikby A, Nilsson BO, Forsey R, et al. The immune risk phenotype is
associated with IL-6 in the terminal decline stage: findings from the
Swedish NONA immune longitudinal study of very late life
functioning. Mech Ageing Dev. 2006;127:695–704.
40. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and
tumor necrosis factor-alpha with muscle mass and muscle strength in
elderly men and women: the Health ABC Study. J Gerontol Med Sci.
2002;57A:M326–M332.
41. Xu Y, Whitmer K. C-reactive protein and cardiovascular disease in
people with diabetes: high-sensitivity CRP testing can help assess risk
for future cardiovascular disease events in this population. Am J Nurs.
2006;106:66–72.
42. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and
loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:
526.e9–526.e17.
43. Salonen EM, Vaheri A. C-reactive protein in acute viral infections.
J Med Virol. 1981;8:161–167.
Received March 30, 2007
Accepted July 20, 2007
Decision Editor: Luigi Ferrucci, MD, PhD
618 AIELLO ET AL.
